🇺🇸 FDA
Patent

US 7879834

Spiroindoline modulators of muscarinic receptors

granted A61KA61K31/435A61K31/438

Quick answer

US patent 7879834 (Spiroindoline modulators of muscarinic receptors) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/435, A61K31/438, A61K31/4747, A61K31/55